PRESTIGE CONSUMER HEALTHCARE INC. Gain (Loss) on Disposition of Assets
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Gain (Loss) on Disposition of Assets of -$51.81 million for the 9-month period ending 2016-12-31, per its 10-Q filed 2017-02-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2017-02-02
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for the quarter ending 2016-12-31 was $3.31M.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for the quarter ending 2015-03-31 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for the quarter ending 2014-12-31 was $1.13M.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for fiscal 2015 was $1.13M.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for fiscal 2014 was $0.00.
- PRESTIGE CONSUMER HEALTHCARE INC. gain (loss) on disposition of assets for fiscal 2013 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2016-12-31 | $3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-02 | -$51.81M 10-Q · filed 2017-02-02 | ||
| 2016-09-30 | -$55.11M 10-Q · filed 2016-11-03 | |||
| 2015-12-31 | $0.00 10-Q · filed 2016-02-04 | $0.00 10-Q · filed 2017-02-02 | ||
| 2015-09-30 | $36.00K 10-Q · filed 2016-11-03 | |||
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-14 | $1.13M derived: sum of 2 quarters · filed 2016-02-04 | $1.13M 10-K · filed 2015-05-14 | |
| 2014-12-31 | $1.13M 10-Q · filed 2016-02-04 | $1.13M 10-Q · filed 2016-02-04 | ||
| 2014-03-31 | $0.00 10-K · filed 2015-05-14 | |||
| 2013-03-31 | $0.00 10-K · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |